Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registrySalomon M. Stemmer, Nicky Liebermann, Kevin Isaacs et al.|npj Breast Cancer|2017Cited by 70
Oral Bisphosphonates and Improved Survival of Breast CancerGad Rennert, Hedy S. Rennert, Mila Pinchev et al.|Clinical Cancer Research|2016Cited by 48
Phase II national clinical trial of prophylactic irradiation to the contralateral breast for BRCA mutation carriers treated for early breast cancer (EBC).Ella Evron, Benjamin W. Corn, Merav A. Ben David et al.|Journal of Clinical Oncology|2018Cited by 3
Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype.Salomon M. Stemmer, Nicky Liebermann, Mariana Steiner et al.|Journal of Clinical Oncology|2017Cited by 0